Previous OCTA implementations were limited to tabletop clinical OCT systems, which require cooperative and upright patients for imaging. Here, we report on OCTA integrated into our SS-MIOCT system and describe, to our knowledge, its first use in the operating room during examination under anesthesia (EUA) of 2 young children with retinal vascular disease.
Methods
The research system used a 100-kHz swept-source laser (Axsun Technologies) with a center wavelength of 1050 nm. Intraoperative MIOCT angiography (MIOCTA) was performed with the MIOCT scanner and a binocular indirect ophthalmomicroscopic lens (BIOM; Oculus) without microscope illumination. The lens allowed for MIOCTA images to be taken at up to a 30°field of view. The size and location of this field of view is controlled in real time by the operator through manual tracking. Microscope-integrated, swept-source OCTA images were acquired with 300 A-scans per B-scan, 6 repeated B-scans per lateral location, and 150 lateral locations sampled. 6 Total image acquisition time for each MIOCTA scan was 4 seconds. The repeated B-scans were registered with phase correlation to compensate for inter-B-scan motion. Speckle variance was used to compute the angiograms. 10, 11 The inner retinal layers were segmented to create en face projections of the retinal vasculature. 12 Fluorescein angiograms obtained with por- 
Report of Cases

Case 1
A 2-year-old, otherwise healthy boy presented to the pediatric retina service for evaluation of new-onset esotropia and was found to have unilateral vitreous hemorrhage of the right eye. He underwent vitrectomy to remove old vitreous hemorrhage and was found to have a presumed vascular stump superonasal to the optic disc, with focal adherent vitreous and blood but no clear vascular anomaly. He returned 4 months after surgery for a second EUA, fluorescein angiography (FA), and research MIOCTA. 
Case 2
A 7-month-old infant girl (born between 31 and 32 weeks' gestation owing to oligohydramnios with a birth weight of 1134 g and requiring a short stay in the neonatal intensive care unit) was referred to the pediatric retina service for evaluation. She had a history of peripheral laser treatment in both eyes for what was described as stage 3 retinopathy of prematurity. During the initial EUA, she was found to have 360°laser scars in both eyes and a temporal neovascular ridge posterior to laser scars in the right eye. In the left eye, she had a partial vitreous detachment with subhyaloid hemorrhage, macular fold with epiretinal membrane, and neovascularization temporally. She underwent fill-in laser photocoagulation in the right eye and vitrectomy, membrane peel, and endolaser in the left eye. Based on her gestational age and the late onset of progressive neovascularization, she was diagnosed with familial exudative vitreoretinopathy.
14 She received additional laser photocoagulation to nonperfused retina in both eyes during follow-up EUAs. Six months after the initial surgery during another EUA with FA, she underwent research MIOCTA. MIOCTA showed a vascular pattern similar to that seen on FA as well as fine perifoveal vasculature that was not evident on the FA (Figure, B and D) . In the left eye, MIOCTA of the retinal periphery demonstrated disorganized peripheral microvasculature adjacent to preexisting laser scars that were difficult to discern on FA (Figure, C) . Although a limitation of OCTA is the absence of fluorescein leakage as a marker of abnormal retinal vessels, these fine vascular abnormalities seen on MIOCTA were not masked by leakage or staining from preexisting laser scars that can obsure them on FA. In the right eye, the peripapillary capillary network was evident (Figure, D) . The peripheral vascular capillary network in the temporal periphery was more organized compared with the network in the left eye. Because of the leakage noted on FA, additional laser treatment was applied to temporal nonperfused retina in both eyes.
Discussion
These 2 cases illustrate, to our knowledge, the first use of MIOCTA in young children with retinal vascular disease. In the second case, MIOCTA allowed study of pathological changes in smaller retinal vessels in the retinal periphery that were obscured in FA by leakage or staining. Although a limitation of OCTA is that this imaging method does not reveal sites of vascular leakage, we recognize that FA is a time-dependent procedure and that, once leakage has occurred, it is difficult to obtain imaging of the
Key Points
Question Is it possible to perform optical coherence tomography angiography in the operating room?
Findings In this case report of 2 young children with retinal vascular disease who underwent microscope-integrated, intraoperative optical coherence tomography angiography during examination under anesthesia, the microscope-integrated optical coherence tomography angiograms showed more detailed retinal vasculature than was visible in fluorescein angiographic images, especially in areas of previous laser treatment.
Meaning Intraoperative optical coherence tomography angiography allowed detailed evaluation of retinal vasculature without injection of fluorescein dye in 2 young children who could not cooperate with in-office examinations, suggesting the feasibility of this procedure for similar situations. microvasculature in that area (Figure, C) . Our MIOCTA system allowed noninvasive retinal vasculature imaging in supine infants who could not be imaged with the available commercial OCTA systems. A current limitation of this MIOCTA system is that imaging of the peripheral retina is still limited to the midperiphery. A potential application of this system includes monitoring for global or regional loss or gain in perfused vessels during vitreoretinal surgery, such as on removal of fibrovascular proliferation and release of traction during vitreoretinal surgery for pediatric familial exudative vitreoretinopathy or for adults with proliferative diabetic retinopathy. The intense interest in OCTA for vitreoretinal applications has led to its swift rise in popularity in the clinical setting and important advances in our knowledge and application of OCTA for retinal diseases among adults and children (but not previously among infants). [7] [8] [9] This SS-MIOCT system allowed for the use of MIOCTA and real-time OCT. Further image processing and optimization of image capture are needed to segment layers of deep and superficial capillary network and choroidal vasculature. Improved image capture and processing speed will allow real-time feedback. Enhancement of image resolution and further correlation between FA and MIOCTA images will validate the current system.
Limitations
Our current case report analysis is limited by its small sample size. More patients are being enrolled to analyze additional vascular patterns in children with retinal vascular disease.
Conclusions
The use of MIOCTA to capture images of the macular and midperipheral retinal vascular networks is feasible in supine infants with an SS-MIOCT system. Further optimization and use of this system may provide important insights into neurovascular patterning during human development and disease as well as vascular changes and complications during vitreoretinal surgery.
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